Texas’ medical marijuana program is expanding, with new laws now in effect that increase access for patients across the state, including in North Texas. While much of the debate in 2025 centered on ...

A new process designed to make your visit to the Department of Motor Vehicles faster and more efficient begins on Monday. It's called QLESS, and it will allow people to join a virtual queue or ...

Basic tutorial to Using Array in Blender, Slow and Fast motion. 00:00 Preview 00:23 Cube 01:03 Use Arrays 01:47 Reposition the Box 02:33 Split big box into small boxes 03:16 Rigid Body 04:19 Light and ...

Sarah Bradley is a writer with six years of experience creating personal essays, reported features, and content related to health and parenting topics. Susan Bard, MD, is a board-certified general and ...

#355 has introduced a change while computing isEmpty which involve an integer (signed) division by 2 in order to correctly account for the adjusted producer sequence value while resizing. e.g.

Abstract: In this paper, we consider the array synthesis with low sidelobe level using two-way array factor (AF), which is defined as the product of the factors in transmit and receive AFs. Utilizing ...

Private artificial intelligence companies will soon have a say in determining traditional Medicare patients’ eligibility for certain procedures in Washington state under a pilot program launching next ...

A new pilot program from CMS will require prior authorization, or pre-approval, from insurers for certain medical procedures. The government says the program will test whether it can reduce waste, ...

A new Medicare pilot program will require prior authorization for certain medical procedures, using AI to approve or deny coverage A new program from the Centers for Medicare and Medicaid Services ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. OKLAHOMA CITY (KFOR) – Artificial ...

US Food and Drug Administration (FDA) has accepted the company’s Type C meeting request and SKNJCT-003 Phase 2 study has randomized more than 75% of patients Philadelphia, Pennsylvania--(Newsfile Corp ...